PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
34977009-9	2021	Finally, an overall survival assay further revealed that both a high expression of YAP and a low expression of GPX4 were correlated with increased survival of HCC patients with sorafenib treatment, which had been proven to be an inducer for ferroptosis by inhibition of the xc-amino acid antiporter.	Sorafenib	177-186	glutathione peroxidase 4	Homo sapiens	111-115	
34530350-6	2021	The overexpression of GPX4 or activation of Keap1/Nrf2 reverses the effects of the downregulation of SIRT6 on sorafenib-induced ferroptosis.	Sorafenib	110-119	glutathione peroxidase 4	Homo sapiens	22-26	
34530350-7	2021	Thus, targeting the SIRT6/Keap1/Nrf2/GPX4 signalling pathway may be a potential strategy for overcoming sorafenib resistance in GC.	Sorafenib	104-113	glutathione peroxidase 4	Homo sapiens	37-41